Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 4.57 USD 0.44%
Market Cap: 91.4m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Journey Medical Corp
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Journey Medical Corp
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Journey Medical Corp
NASDAQ:DERM
Tax Provision
-$221k
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Tax Provision
-$2.9B
CAGR 3-Years
-19%
CAGR 5-Years
-7%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Tax Provision
-$367m
CAGR 3-Years
32%
CAGR 5-Years
17%
CAGR 10-Years
4%
Pfizer Inc
NYSE:PFE
Tax Provision
$402m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Tax Provision
-$1.6B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Tax Provision
-$1.8B
CAGR 3-Years
-30%
CAGR 5-Years
-80%
CAGR 10-Years
-10%
No Stocks Found

Journey Medical Corp
Glance View

Market Cap
94.7m USD
Industry
Pharmaceuticals

Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.

DERM Intrinsic Value
4.79 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Journey Medical Corp's Tax Provision?
Tax Provision
-221k USD

Based on the financial report for Dec 31, 2023, Journey Medical Corp's Tax Provision amounts to -221k USD.

What is Journey Medical Corp's Tax Provision growth rate?
Tax Provision CAGR 3Y
51%

Over the last year, the Tax Provision growth was -268%. The average annual Tax Provision growth rates for Journey Medical Corp have been 51% over the past three years .

Back to Top